Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3044291	s-thevulg	— (—)	39	41	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, hospital admission 2, infections

11.89

9.69

1.0

1.1

—

Asthma-related infections

11.89

9.69

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

7.46

7.83

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

7.89

7.76

1.0

1.1

—

Asthma-related pneumonia

11.80

7.55

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

11.80

7.55

1.0

1.1

—

Asthma-related pneumonia or sepsis

11.80

7.55

1.0

1.1

—

9.69

7.47

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9.69

7.47

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

7.11

7.28

1.1

1.0

—

All pneumoniae

7.07

7.25

1.1

1.0

—

Mycoses

15.73

7.22

1.2

1.0

—

Asthma, including avohilmo

5.05

6.99

1.0

1.1

—

Influenza and pneumonia

6.73

6.96

1.1

1.0

—

Pneumonia, organism unspecified

7.01

6.91

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6.44

6.53

1.1

1.0

—

10.91

6.25

1.0

1.1

—

Chronic lower respiratory diseases

5.01

6.03

1.1

1.0

—

Oral corticosteroids

5.93

6.00

1.0

1.1

—

ILD medications

4.82

5.86

1.1

—

Mycoses

5.67

5.62

1.1

1.0

—

Inflammatory bowel disease treatment related agents

4.66

5.39

1.0

1.1

—

Asthma/COPD (KELA code 203)

6.00

5.24

1.1

1.0

—

Aspergillosis

+∞

5.22

1.2

0.0

—

First line medication for Crohn's disease

4.50

5.13

1.0

1.1

—

Diagnoses used for exclusion with ILD

13.34

5.07

1.1

1.0

—

Cough

9.46

4.84

1.1

1.0

—

COPD/asthma/ILD related infections

6.51

4.79

1.2

1.0

—

COPD/asthma related infections

6.51

4.79

1.2

1.0

—

Acute sinusitis

7.71

4.78

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.93

4.66

1.0

1.1

—

Ethmoidectomy

14.01

4.57

1.1

1.0

—

Candidiasis

14.01

4.57

1.0

—

Other diseases of pleura

6.74

4.39

1.1

1.0

—

Abnormal findings on diagnostic imaging of lung

6.39

4.31

1.1

1.0

—

Chronic sinusitis

8.88

4.27

1.3

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7.29

4.26

1.1

1.0

—

5.17

4.17

1.2

1.0

—

Haemorrhage from respiratory passages

6.56

3.57

1.1

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

7.78

3.55

1.1

1.0

—

Other diseases of upper respiratory tract

3.98

3.42

1.2

1.0

—

Abnormalities of breathing

4.26

3.21

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.07

3.07

1.1

1.0

—

Pleural effusion

10.01

2.98

1.2

1.0

—

Special screening examination for other diseases and disorders

10.00

2.98

1.0

—

Bleeding

3.72

2.97

1.2

1.0

—

Acute upper respiratory infections

3.52

2.95

1.2

1.0

—

Voice disturbances

6.67

2.86

1.0

—

Bacterial pneumonia (organism specified)

5.29

2.79

1.0

1.1

—

Dermatitis

4.43

2.78

1.1

—

Fever of other and unknown origin

4.00

2.78

1.0

1.1

—

Sulfasalazine

8.34

2.75

1.0

1.2

—

ILD medications: immunosuppressive drugs

4.37

2.72

1.1

—

Symptoms and signs involving speech and voice

6.00

2.69

1.0

—

Obesity related asthma

6.00

2.69

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

4.23

2.57

1.3

1.0

—

Polycystic ovarian syndrome, consortium definition

4.61

2.35

1.0

1.2

—

Disorders of other endocrine glands

4.54

2.24

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3.00

2.21

1.1

1.0

—

Acute bronchitis

4.20

2.11

1.0

—

Any gastric operation

3.22

2.07

1.1

1.0

—

GASTRO-related operations

3.22

2.07

1.1

1.0

—

L04AX Other immunosuppressants

3.50

2.05

1.0

1.1

—

Other acute lower respiratory infections

3.51

2.04

1.1

1.0

—

Constipation

2.77

2.03

1.0

1.1

—

Other disorders of urethra and urinary system

3.61

2.01

1.0

1.1

—

Other diseases of urinary system

2.81

1.99

1.0

1.1

—

All kidney diseases

2.73

1.99

1.0

1.1

—

Second line medication for Crohn's disease

3.33

1.96

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

3.04

1.96

1.1

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

3.40

1.95

1.1

1.0

—

Used for control exclusion in common control thyroid runs

2.65

1.88

1.0

—

Other diseases of the digestive system

4.17

1.82

1.2

1.0

—

GI-bleeding

4.17

1.82

1.2

1.0

—

Other viral diseases

4.15

1.82

1.2

1.0

—

Dyspnoea

2.66

1.80

1.0

1.1

—

Ischaemic heart disease, wide definition

2.91

1.78

1.0

1.1

—

Dermatitis and eczema

2.43

1.73

1.1

1.0

—

Gastrointestinal diseases

3.76

1.72

1.2

1.0

—

Diseases of male genital organs

3.21

1.70

1.0

—

Other viral diseases

3.82

1.70

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.49

1.63

1.0

—

Noninflammatory disorders of female genital tract

4.18

1.62

1.0

1.3

—

Other and unspecified dermatitis

3.57

1.61

1.2

1.1

—

Disorders of eyelid, lacrimal system and orbit

0.00

1.55

0.0

1.1

—

Cystitis

2.77

1.52

1.0

1.1

—

Reimbursement for rheumatic diseases

2.84

1.49

1.0

1.1

—

Osteopathies and chondropathies

2.79

1.46

1.0

1.1

—

Shoulder lesions

0.00

1.40

0.0

1.1

—

Metabolic disorders

2.29

1.38

1.1

1.0

—

Depression or dysthymia

2.60

1.35

1.0

—

Autoimmune diseases excluding thyroid diseases

2.27

1.35

1.0

—

Coronary atherosclerosis

2.71

1.34

1.0

1.1

—

Other antidepressants

2.17

1.32

1.1

1.0

—

Diseases of the digestive system

2.76

1.27

1.2

1.0

—

Persons encountering health services in circumstances related to reproduction

2.53

1.26

1.0

1.1

—

Ischemic heart diseases

2.29

1.24

1.0

1.1

—

Anxiety disorders, excluding more controls

2.40

1.13

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

2.34

1.11

1.1

1.0

—

Other retinal disorders

2.27

1.10

1.1

1.0

—

Bronchitis

2.10

1.08

1.2

1.0

—

Diseases of the skin and subcutaneous tissue

2.05

1.07

1.1

1.0

—

Psychiatric diseases

2.05

1.06

1.1

1.0

—

Percutaneous Coronary Intervention

2.14

1.04

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

2.14

1.04

1.0

1.1

—

Anxiety disorders

2.12

1.04

1.1

1.0

—

Necrosis of pulp, including avohilmo

2.27

1.03

1.2

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.96

1.03

1.1

1.0

—

Pure hypercholesterolaemia

2.08

1.01

1.0

—

Diseases of middle ear and mastoid

2.27

1.01

1.2

1.0

—

Medical observation and evaluation for suspected diseases and conditions

2.11

1.01

1.1

1.0

—

Genitourinary diseases

2.51

0.99

1.0

1.2

—

Persons encountering health services for examination and investigation

2.06

0.99

1.1

1.0

—

Pain (limb, back, neck, head abdominally)

2.06

0.99

1.0

1.1

—

Certain infectious and parasitic diseases

2.06

0.99

1.1

1.0

—

Codeine or tramadol medication

1.95

0.98

1.0

1.1

—

Hypothyroidism, other/unspecified

2.00

0.98

1.1

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.00

0.97

1.1

1.0

—

Persons encountering health services in other circumstances, wide

1.85

0.97

1.1

1.0

—

Intracranial injury

0.00

0.97

0.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

2.02

0.92

1.3

1.0

—

Mood [affective] disorders

1.99

0.91

1.0

1.1

—

Mood disorders

1.99

0.91

1.0

1.1

—

Codeine

1.98

0.91

1.0

1.1

—

Certain infectious and parasitic diseases

2.15

0.89

1.2

1.0

—

Exposure to unspecified factor

1.86

0.87

1.0

1.1

—

Other bacterial diseases

1.85

0.87

1.1

1.0

—

Other bacterial diseases

1.81

0.85

1.1

1.0

—

Injury, poisoning and certain other consequences of external causes

2.01

0.84

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.78

0.83

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.81

0.0

1.0

—

Malignant neoplasm of skin

0.00

0.81

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.81

0.0

1.0

—

Basal cell carcinoma, including avohilmo

0.00

0.81

0.0

1.0

—

Basal cell carcinoma

0.00

0.81

0.0

1.0

—

Diabetes, varying definitions

1.74

0.81

1.1

1.0

—

Diabetes mellitus

1.73

0.81

1.1

1.0

—

Selective serotonin reuptake inhibitors

1.81

0.79

1.1

1.0

—

Intestinal infectious diseases

1.77

0.78

1.1

1.0

—

Erysipelas

0.00

0.78

0.0

1.0

—

Benign neoplasm: Colon

0.00

0.77

0.0

1.0

—

Fracture of lower leg, including ankle

0.00

0.77

0.0

1.1

—

Pain in throat and chest

2.14

0.75

1.0

—

Dental pulpitis, including avohilmo

1.89

0.75

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.88

0.75

1.0

—

Major coronary heart disease event

1.84

0.74

1.0

1.1

—

Disorders of choroid and retina

1.78

0.72

1.1

1.0

—

Emergency coronary revascularization (for ACS)

1.77

0.72

1.0

—

Intestinal infectious diseases

1.77

0.72

1.1

1.0

—

Acute tubulo-interstitial nephritis

1.96

0.71

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.75

0.71

1.1

1.0

—

Mood disorders, excluding more controls

1.74

0.70

1.0

—

Hard cardiovascular diseases

1.74

0.70

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.65

0.67

1.0

—

Gastro-oesophageal reflux disease

1.80

0.66

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.83

0.66

1.0

—

Autoimmune diseases related-to ILD

1.78

0.65

1.0

1.1

—

Diseases of the ear and mastoid process

1.75

0.65

1.3

1.0

—

Injuries to the ankle and foot

1.78

0.65

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.78

0.65

1.2

1.0

—

Spondylosis

1.77

0.65

1.0

—

Autoimmune diseases

1.69

0.64

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

1.67

0.63

1.1

1.0

—

Any mental disorder

1.60

0.62

1.1

1.0

—

Syncope and collapse

0.00

0.60

0.0

1.1

—

Other disorders of eyelid

0.00

0.60

0.0

1.1

—

Hernia of abdominal wall

0.00

0.60

0.0

1.0

—

Disorders of lacrimal system

0.00

0.60

0.0

1.1

—

Unspecified fall

0.00

0.60

0.0

1.0

—

Cholelithiasis

1.80

0.59

1.2

1.0

—

Neurotic, stress-related and somatoform disorders

1.75

0.58

1.2

1.0

—

Parasetamol

1.69

0.57

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.68

0.57

1.2

1.0

—

Neoplasms

1.67

0.57

1.0

1.1

—

External causes of morbidity and mortality

1.67

0.57

1.0

1.1

—

Low back pain

1.66

0.56

1.0

1.1

—

Depression

1.63

0.55

1.0

1.1

—

Renal tubulo-interstitial diseases

1.60

0.54

1.0

1.1

—

Other disorders of ear

1.57

0.54

1.2

1.0

—

Spondylopathies

1.56

0.53

1.0

—

Opioids

1.65

0.51

1.0

1.1

—

Neurological diseases

1.60

0.50

1.0

1.1

—

Hernia

1.56

0.49

1.0

1.1

—

Benign neoplasms

1.48

0.48

1.0

1.1

—

Lower back pain or/and sciatica

1.47

0.47

1.0

1.1

—

General symptoms and signs

1.46

0.47

1.0

1.1

—

Diabetes medication

1.43

0.46

1.1

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.67

0.44

1.0

1.1

—

Tramadol

1.62

0.43

1.0

1.1

—

Exposure to other specified factors

1.64

0.43

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.63

0.43

1.2

1.0

—

Dental caries, including avohilmo

1.60

0.43

1.0

—

Statin medication

1.56

0.42

1.0

1.1

—

Other neurological diseases

1.57

0.42

1.0

1.1

—

Any death

1.56

0.42

1.0

—

Insulin medication

1.56

0.42

1.2

1.0

—

Conjunctivitis

1.55

0.42

1.0

1.1

—

Inguinal hernia

1.52

0.41

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

0.00

0.41

0.0

1.0

—

Actinic keratosis

0.00

0.41

0.0

1.0

—

Injuries to the elbow and forearm

1.52

0.41

1.0

1.1

—

0.00

0.41

0.0

1.0

—

Umbilical hernia

0.00

0.41

0.0

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

Schizophrenia or delusion

0.00

0.41

0.0

1.1

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.41

0.0

1.1

—

Obesity, other/unspecified

0.00

0.41

0.0

1.1

—

Other disorders of lacrimal gland

0.00

0.41

0.0

1.1

—

Caries of dentine, including avohilmo

1.50

0.41

1.2

1.0

—

Glucosamine medication

0.00

0.41

0.0

1.1

—

Acute alcohol intoxication

0.00

0.41

0.0

1.1

—

Heart failure and coronary heart disease

0.00

0.41

0.0

1.0

—

Non-selective monoamine reuptake inhibitors

0.00

0.41

0.0

1.0

—

Hyperlipidaemia, other/unspecified

0.00

0.40

0.0

1.0

—

In situ neoplasms

0.00

0.40

0.0

1.1

—

Cervical disc disorders

0.00

0.40

0.0

1.1

—

Haemorrhoids and perianal venous thrombosis

0.00

0.40

0.0

1.1

—

Sensorineural hearing loss

1.48

0.40

1.2

1.0

—

Internal derangement of knee

0.00

0.40

0.0

1.1

—

Complications of procedures, not elsewhere classified

1.43

0.39

1.0

1.1

—

Disorders of conjunctiva

1.38

0.38

1.0

1.1

—

Disorders of the thyroid gland

1.45

0.36

1.0

—

Diseases of oesophagus, stomach and duodenum

1.38

0.35

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.37

0.35

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

1.37

0.34

1.0

1.1

—

Benzodiazepine use

1.33

0.34

1.0

1.1

—

Sleep apnoea, including avohilmo

1.33

0.33

1.0

1.1

—

Episodal and paroxysmal disorders

1.42

0.33

1.0

1.1

—

Abdominal and pelvic pain

1.41

0.33

1.0

1.1

—

Dorsalgia

1.39

0.32

1.0

1.1

—

Polyarthropathies

1.36

0.24

1.0

1.1

—

Conductive and sensorineural hearing loss

1.35

0.24

1.2

1.0

—

Heart failure, not strict

1.31

0.23

1.0

—

Hypertensive diseases

1.28

0.23

1.0

1.1

—

Hypertension

1.28

0.23

1.0

1.1

—

Type 2 diabetes, wide definition

1.23

0.22

1.0

—

Other intervertebral disc disorders

1.20

0.22

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.21

0.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.21

0.0

1.1

—

Schizophrenia or delusion, excluding more controls

0.00

0.21

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.21

0.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

1.1

—

Paralytic ileus and intestinal obstruction

0.00

0.21

0.0

1.0

—

Abnormal involuntary movements

0.00

0.21

0.0

1.1

—

Injury of eye and orbit

0.00

0.21

0.0

1.1

—

Open wound of lower leg

0.00

0.21

0.0

1.1

—

Alcohol abuse, main dg

0.00

0.21

0.0

1.1

—

severe traumatic brain injury, does not include concussion

0.00

0.21

0.0

1.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Corneal ulcer

0.00

0.21

0.0

1.0

—

Acute appendicitis, with complications

0.00

0.21

0.0

1.0

—

Acute and subacute iridocyclitis

0.00

0.21

0.0

1.0

—

Anterior Iridocyclitis

0.00

0.21

0.0

1.0

—

Implicit viral Sepsis

0.00

0.21

0.0

1.1

—

Viral Sepsis

0.00

0.21

0.0

1.1

—

Superficial injury of wrist and hand

0.00

0.21

0.0

1.1

—

Polyuria

0.00

0.21

0.0

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.1

—

Subjective visual disturbances

0.00

0.21

0.0

1.1

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.1

—

Speech therapy

0.00

0.21

0.0

1.1

—

Presence of other devices

0.00

0.21

0.0

1.0

—

Implicit viral Sepsis

0.00

0.21

0.0

1.1

—

Primary open-angle glaucoma

0.00

0.21

0.0

1.0

—

Sulfonylureas

0.00

0.21

0.0

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

0.21

0.0

1.0

—

Acute alcohol intoxication, ICD10

0.00

0.21

0.0

1.1

—

Iridocyclitis

0.00

0.21

0.0

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

0.00

0.21

0.0

1.0

—

Covid-19 suspected case

0.00

0.21

0.0

1.1

—

Impingement syndrome of shoulder

0.00

0.21

0.0

1.1

—

Specific personality disorders

0.00

0.21

0.0

1.1

—

Cervicobrachial syndrome

0.00

0.21

0.0

1.0

—

Erosion of teeth , including avohilmo

0.00

0.21

0.0

1.1

—

Fall on and from stairs and steps

0.00

0.21

0.0

1.1

—

Blepharochalasis

0.00

0.21

0.0

1.1

—

Personality disorders

0.00

0.21

0.0

1.1

—

Retinal detachments and breaks

0.00

0.21

0.0

1.0

—

Intestinal stricture

0.00

0.21

0.0

1.0

—

Superficial injury of head

0.00

0.21

0.0

1.1

—

Other fall from one level to another

0.00

0.21

0.0

1.1

—

Oedema, not elsewhere classified

0.00

0.21

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

0.21

0.0

1.0

—

Calcific aortic valvular stenosis, operated

0.00

0.21

0.0

1.0

—

Operations 2 for CAVS

0.00

0.21

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.21

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

1.0

—

Type 2 diabetes

1.30

0.21

1.0

—

Ganglion

0.00

0.21

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

0.21

0.0

1.1

—

Disorders of adult personality and behaviour

0.00

0.21

0.0

1.1

—

Extrapyramidal and movement disorders

0.00

0.21

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.00

0.20

0.0

1.1

—

Nerve, nerve root and plexus disorders

1.27

0.20

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.24

0.20

1.0

—

Cutaneous abscess, furuncle and carbuncle

0.00

0.20

0.0

1.1

—

Abrasion of teeth

0.00

0.20

0.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.20

0.20

1.0

1.1

—

Arthropathies

1.17

0.19

1.0

1.1

—

Sleep apnoea

1.16

0.10

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.13

0.10

1.0

—

Type 2 diabetes, definitions combined

1.13

0.10

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.12

0.10

1.0

—

Other heart diseases, wide

1.09

0.10

1.0

1.1

—

Biguanides

1.09

0.10

1.0

—

Other (not insulin) diabetes medications

1.06

0.09

1.0

—

Use of hypnotics and sedatives

1.15

0.09

1.2

1.0

—

Chronic apical periodontitis

1.14

0.09

1.0

1.1

—

Sleep disorders (combined)

1.09

0.09

1.0

1.1

—

Sudden idiopathic hearing loss

0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.0

1.0

—

Hallux rigidus

0.00

0.0

1.1

—

Emphysema

0.00

0.0

1.0

—

Pruritus

0.00

0.0

1.0

—

Other skin changes

0.00

0.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

0.0

1.0

—

Benign neoplasm: Ascending colon

0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.0

—

Inflammatory disease of uterus

0.00

0.0

1.0

—

Progressive vascular leukoencephalopathy

0.00

0.0

1.0

—

Psoriatic and enteropathic arthropathies

0.00

0.0

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.0

—

Enlarged lymph nodes

0.00

0.0

1.2

—

Plantar fascial fibromatosis

0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Bell's palsy

0.00

0.0

1.0

—

Migraine without aura

0.00

0.0

1.1

—

Viral infections of the central nervous system

0.00

0.0

1.0

—

Rheumatism, unspecified

0.00

0.0

1.0

—

Malignant neoplasm of urinary organs

0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

0.0

1.0

—

Reactive arthropathies, FINNGEN

0.00

0.0

1.0

—

Foreign body on external eye

0.00

0.0

1.0

—

Other congenital malformations

0.00

0.0

1.2

—

Metatarsalgia

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.0

1.1

—

Ulcer of lower limb, not elsewhere classified

0.00

0.0

1.0

—

Amputation

0.00

0.0

1.0

—

Event of undetermined intent

0.00

0.0

1.2

—

Dilated cardiomyopathy

0.00

0.0

1.0

—

Diseases of peritoneum

0.00

0.0

1.0

—

Special screening examination for infectious and parasitic diseases

0.00

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.0

—

Perforation of tympanic membrane

0.00

-0.00

0.0

1.0

—

Other and unspecified myopathies

0.00

-0.00

0.0

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.0

—

Retinal vascular occlusion

0.00

-0.00

0.0

1.0

—

Agranulocytosis

0.00

-0.00

0.0

1.0

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

1.0

—

Other keratitis

0.00

-0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

-0.00

0.0

1.0

—

Macular hole

0.00

-0.00

0.0

1.0

—

Other diseases of intestine

0.00

-0.00

0.0

1.0

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Normotensive glaucoma

0.00

-0.00

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Amiodarone users

0.00

-0.00

0.0

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Left bundle-branch block

0.00

-0.00

0.0

1.0

—

Viral warts

0.00

-0.00

0.0

1.2

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.1

—

Familial hypercholesterolemia

0.00

-0.00

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.0

—

Personality disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

-0.00

0.0

1.1

—

Amputation of toe

0.00

-0.00

0.0

1.0

—

Abnormal weight loss

0.00

-0.00

0.0

1.1

—

D07AA Corticosteroids, weak (group I)

0.00

-0.00

0.0

1.1

—

Use of pramipexole

0.00

-0.00

0.0

1.0

—

Other ill-defined and unspecified causes of mortality

0.00

-0.00

0.0

1.0

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Nausea and vomiting

0.00

-0.00

0.0

1.1

—

Unspecified kidney failure

0.00

-0.00

0.0

1.0

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Ill-defined and unknown causes of mortality

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.0

—

Superficial injury of forearm

0.00

-0.00

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

-0.00

0.0

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

1.2

—

Injury of unspecified body region

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

-0.00

0.0

1.2

—

Bitten or struck by other mammals

0.00

-0.00

0.0

1.1

—

Other condition

0.00

-0.00

0.0

1.1

—

Other and unspecified drugs and medicaments

0.00

-0.00

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Unspecified privation

0.00

-0.00

0.0

1.0

—

Personal history of other diseases and conditions

0.00

-0.00

0.0

1.0

—

Olecranon bursitis

0.00

-0.00

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

-0.00

0.0

1.2

—

Other enthesopathy of foot (+metatarsalgia)

0.00

-0.00

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Pain associated with micturition

0.00

-0.00

0.0

1.0

—

Other complications of surgical and medical care, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.00

-0.00

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies (FG)

0.00

-0.00

0.0

1.0

—

Pain in thoracic spine

0.00

-0.00

0.0

1.1

—

Dysphagia

0.00

-0.00

0.0

1.0

—

Other disorders of breast

0.00

-0.00

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Other peripheral vascular diseases

0.00

-0.00

0.0

1.0

—

Complications predominantly related to the puerperium

0.00

-0.00

0.0

1.0

—

Allergic urticaria

0.00

-0.00

0.0

1.0

—

Nail disorders

0.00

-0.00

0.0

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.0

—

Superficial injury of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.1

—

Crohn disease

0.00

-0.00

0.0

1.2

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.1

—

Valvular operations

0.00

-0.00

0.0

1.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of kidney, except renal pelvis

0.00

-0.00

0.0

1.0

—

Assault

0.00

-0.00

0.0

1.1

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Viral infections of the central nervous system

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to tobacco

0.00

-0.00

0.0

1.0

—

Acne vulgaris

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.2

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

1.1

—

Non-follicular lymphoma

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.00

-0.00

0.0

1.1

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Myopia

0.00

-0.00

0.0

1.1

—

Scabies

0.00

-0.00

0.0

1.1

—

Smoking dependency

0.00

-0.00

0.0

1.0

—

Streptococcal septicaemia

0.00

-0.00

0.0

1.0

—

Ptosis of eyelid

0.00

-0.00

0.0

1.0

—

Retinal breaks without detachment

0.00

-0.00

0.0

1.0

—

Vestibular neuronitis

0.00

-0.00

0.0

1.0

—

Diabetic nephropathy

0.00

-0.00

0.0

1.0

—

Pilonidal cyst

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Nummular dermatitis

0.00

-0.00

0.0

1.0

—

Adhesive capsulitis of shoulder

0.00

-0.00

0.0

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

0.00

-0.00

0.0

1.2

—

Hydronephrosis

0.00

-0.00

0.0

1.0

—

Other disorders of patella

0.00

-0.00

0.0

1.0

—

Fibromyalgia

0.00

-0.00

0.0

1.0

—

Other shoulder lesions

0.00

-0.00

0.0

1.0

—

Otalgia

0.00

-0.00

0.0

1.2

—

Unspecified lump in breast

0.00

-0.00

0.0

1.0

—

Lateral epicondylitis

0.00

-0.00

0.0

1.0

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Radiculopathy

0.00

-0.00

0.0

1.0

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Hydrocele

0.00

-0.00

0.0

1.0

—

Achilles tendinitis

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Raynaud syndrome

0.00

-0.00

0.0

1.0

—

Restless leg syndrome

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Gout, unspecified

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.1

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

-0.00

0.0

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Other extrapyramidal and movement disorders in other diseases

0.00

-0.00

0.0

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Other disorders of conjunctiva

0.00

-0.00

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

-0.00

0.0

1.0

—

Retinal vascular disorders

0.00

-0.00

0.0

1.0

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Intracerebral haemorrhage

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Acne

0.00

-0.00

0.0

1.2

—

Other disorders of eye and adnexa

0.00

-0.00

0.0

1.1

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Other joint disorders

1.01

-0.00

1.0

1.1

—

Cerebral cysts

0.00

-0.00

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Graves disease, strict definition

0.00

-0.00

0.0

1.0

—

Other sleep disorders

0.00

-0.00

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

-0.00

0.0

1.2

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Polyp of the female genital tract

0.00

-0.00

0.0

1.2

—

Volume depletion

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Undefined dementia

0.00

-0.00

0.0

1.0

—

Deep endometriosis

0.00

-0.00

0.0

1.0

—

Endometriosis ASRM stages 3,4

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

0.00

-0.00

0.0

1.0

—

conjunctival haemorrhage

0.00

-0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.0

—

Congenital malformations of the circulatory system

0.00

-0.00

0.0

1.1

—

Deep bite

0.00

-0.00

0.0

1.2

—

Other diseases of intestines

0.89

-0.00

1.0

1.1

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Noninfectious colitis NAS

0.00

-0.00

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

-0.00

0.0

1.2

—

Dorsopathies

0.94

-0.00

1.0

1.1

—

Alcohol abuse, main dg, excluding more controls

0.00

-0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Haemangioma, any site

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

1.0

—

Vascular dementia

0.00

-0.00

0.0

1.0

—

Macular pucker

0.00

-0.00

0.0

1.0

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.0

—

Ventral hernia

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.0

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.0

—

Abscess of anal and rectal regions

0.00

-0.00

0.0

1.0

—

Other diseases of liver

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Haemorrhage in early pregnancy

0.00

-0.00

0.0

1.2

—

All dysplastic lesions of the cervix uteri

0.00

-0.00

0.0

1.0

—

Schizophrenia

0.00

-0.00

0.0

1.0

—

Use of antiglaucoma preparations and miotics

0.00

-0.00

0.0

1.0

—

Herpesviral [herpes simplex] infections

0.00

-0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

-0.00

0.0

1.0

—

Coeliac disease

0.00

-0.00

0.0

1.0

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.0

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with diffuse goitre

0.00

-0.00

0.0

1.0

—

Benign neoplasm of breast

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

-0.00

0.0

1.0

—

Primary open-angle glaucoma, strict

0.00

-0.00

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

1.1

—

Chalazion

0.00

-0.00

0.0

1.0

—

Diplopia

0.00

-0.00

0.0

1.1

—

Cervicalgia

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS